| Literature DB >> 35509189 |
Abstract
The body and brain are in constant two-way communication. Driving this communication is a region in the lower brainstem: the dorsal vagal complex. Within the dorsal vagal complex, the caudal nucleus of the solitary tract (cNTS) is a major first stop for incoming information from the body to the brain carried by the vagus nerve. The anatomy of this region makes it ideally positioned to respond to signals of change in both emotional and bodily states. In turn, the cNTS controls the activity of regions throughout the brain that are involved in the control of both behaviour and physiology. This review is intended to help anyone with an interest in the cNTS. First, I provide an overview of the architecture of the cNTS and outline the wide range of neurotransmitters expressed in subsets of neurons in the cNTS. Next, in detail, I discuss the known inputs and outputs of the cNTS and briefly highlight what is known regarding the neurochemical makeup and function of those connections. Then, I discuss one group of cNTS neurons: glucagon-like peptide-1 (GLP-1)-expressing neurons. GLP-1 neurons serve as a good example of a group of cNTS neurons, which receive input from varied sources and have the ability to modulate both behaviour and physiology. Finally, I consider what we might learn about other cNTS neurons from our study of GLP-1 neurons and why it is important to remember that the manipulation of molecularly defined subsets of cNTS neurons is likely to affect physiology and behaviours beyond those monitored in individual experiments.Entities:
Keywords: afferent; anatomy; efferent; glucagon-like peptide-1; neuropeptides; nucleus of the solitary tract
Mesh:
Substances:
Year: 2022 PMID: 35509189 PMCID: PMC9286632 DOI: 10.1111/jne.13132
Source DB: PubMed Journal: J Neuroendocrinol ISSN: 0953-8194 Impact factor: 3.870
FIGURE 1Anatomical organization of the caudal nucleus of the solitary tract (cNTS). (A) Coronal brainstem section containing the cNTS. The hypoglossal nucleus (XII) and the intermediate reticular nucleus (IRT) are indicated as landmarks. Labelled for cFOS (black product) and glucagon‐like peptide‐1 (GLP‐1) (brown product) using immunohistochemistry. Scale bar = 400 μm. (B) Higher magnification of the dorsal vagal complex containing the area postrema (AP), cNTS and dorsal motor nucleus of the vagus (DMV). Labelled for cFOS (black product) and GLP‐1 (brown product) using immunohistochemistry. Scale bar = 200 μm. (C) Schematic of mouse brain with rostral and caudal NTS indicated in green and orange. (D) Schematics of coronal sections through different rostrocaudal levels of the NTS with the rostral part indicated in green and the caudal part indicated in orange. (E) Schematics of cNTS at different rostrocaudal levels (indicated in millimetre from Bregma) with the subnuclei indicated. 4V, fourth ventricle; Ts, solitary tract; co, commissural nucleus; me, medial nucleus; v, ventral nucleus; cl, caudolateral nucleus; pc, parvocellular nucleus; dm, dorsomedial nucleus; ce, central nucleus; vl, ventrolateral medulla; dl, dorsolateral medulla
FIGURE 2Known peptidergic cell types of the caudal nucleus of the solitary tract (cNTS). Cell types with approximate locations based on published studies referenced in Table 1. Highlighted in green are cell types that have been manipulated chemo‐ or optogenetically to investigate their function as indicated in Table 1. There is conflicting evidence on the location of cocaine‐ and amphetamine‐regulated transcript (CART) neurons, possibly as a result of species differences. For details, see Table 1. Abbreviations are indicated in Table 2
Expression of neuropeptides and selected small‐molecular neurotransmitters, intracellular proteins, and receptors in the caudal nucleus of the solitary tract (cNTS)
| Neuronal population | Detected in species | Response to cell type‐specific manipulations | References |
|---|---|---|---|
|
| |||
| Bombesin‐like peptides (BB) | Mouse, rat | – |
|
| Cocaine‐ and amphetamine‐regulated transcript (CART) | Mouse, rat | – |
|
| Cholecystokinin‐8 (CCK) | Mouse, rat |
Chemogenetic activation (whole population): food intake↓; conditioned place avoidance; condition taste avoidance Optogenetic activation (fibres in parabrachial nucleus [PBN]): food intake↓; real‐time place avoidance Optogenetic activation (fibres in paraventricular nucleus [PVN]): food intake↓; real‐time place preference |
|
| Corticotropin‐releasing hormone (CRH) | Mouse, rat | – |
|
| Dynorphin (Dyn) | Rat | – |
|
| Enkephalin (Enk) | Rat, mouse | Chemogenetic activation: novel flavour preference↑ |
|
| Galanin (Gal) | Rat, mouse | – |
|
| Glucagon‐like peptide‐1 (GLP1) | Mouse, rat |
Optogenetic activation (whole population and fibres in PVN): food intake↓; Chemogenetic activation: food intake↓; heart rate↑; locomotion↓; glucose production↓; drug reward↓. Chemogenetic inhibition: fast‐refeed↑; stress‐induced hypophagia↓ |
|
| Neuronatin (Nnat) | Rat | – |
|
| Neuropeptide Y (NPY) | Mouse, rat | Chemogenetic activation: food intake↑ |
|
| Neurotensin (Nts) | Mouse, rat | – |
|
| Nesfatin‐1 (Nfat) | Mouse, rat | – |
|
| Proopiomelanocortin (POMC) | Mouse, rat |
Optogenetic activation: heart rate↓; breathing↓; Chemogenetic activation: nociception↓; food intake↓; Ablation: food intake↑ |
|
| Prolactin‐releasing peptide (PrRP) | Mouse, rat |
Chemogenetic activation: food intake↓ Chemogenetic inhibition: fast‐refeed↑ Ablation: diet‐induced obesity↑ |
|
| Tachykinin/substance P (Tac) | Rat | – |
|
|
| |||
| GABA | Mouse, rat | Chemogenetic activation: blood glucose↑ |
|
| Glutamate | Mouse, rat | Optogenetic activation: renal and phrenic sympathetic nerve activity↑ |
|
| Noradrenaline (NA) | Mouse, rat |
Chemogenetic activation (NET‐Cre; DBH‐Cre): food intake↓ Optogenetic activation (DBH‐cre; fibres in PBN): food intake↓ Optogenetic activation (TH‐cre; fibres in Arc): food intake↑ |
|
|
| |||
| Brain‐derived neurotrophic factor (BDNF) | Mouse, rat | – |
|
| 11β‐hydroxysteroid dehydrogenase 2 (HSD2) | Mouse |
Ablation: sodium appetite↓ Chemogenetic activation: sodium appetite↑ Optogenetic activation (fibres in bed nucleus of the stria terminalis): sodium appetite↑ |
|
| Phox2B | Mouse, rat |
Chemogenetic activation: breathing↑; food intake↓ Ablation: breathing↓ |
|
| Neuronal nitric oxide synthase (nNOS) | Rat | – |
|
|
| |||
| Angiotensin‐II receptor (AT2R) | Mouse | Optogenetic activation: systemic blood pressure↑; heart rate↑ |
|
| Glucose transporter 2 (GLUT2) | Mouse | Optogenetic activation: vagal efferent activity↑; blood glucagon↑ |
|
| GLP1 receptor (GLP1R) | Rat, mouse | – |
|
| Leptin receptor (LEPR) | Mouse, rat |
Optogenetic and chemogenetic activation (whole population): breathing↑; food intake↓ Chemogenetic activation (PBN‐projecting): breathing↑ |
|
| Calcitonin receptor (CALCR) | Mouse |
Chemogenetic activation: food intake↓ Optogenetic activation (fibres in PBN): food intake↓ Chemogenetic inhibition: food intake↑ Ablation: food intake↑ |
|
| 5‐hydroxytryptamine 2C receptor (5‐HT2CR) | Mouse, rat |
Chemogenetic activation: food intake↓ |
|
Note: Only those with anatomical evidence for expression within neuronal populations resident in the NTS are included. As such, evidence based on physiological or behavioural responses to microinjection of agonists or antagonists into the cNTS has not been included. Also indicated are effects of opto‐ or chemogenetic manipulations of the cellular activity of the particular subpopulation. The list of receptors and transporters is not exhaustive, but highlights a few well‐studied examples.
Abbreviations: DBH, Dopamine β‐hydroxylase; NET, Norepinephrine transporter; TH, Tyrosine hydroxylase.
Abbreviations
| IX | 9th cranial nerve, glossopharyngeal nerve |
|---|---|
| X | 10th cranial nerve, vagus nerve |
| AAV | Adeno‐associated virus |
| AGRP | Agouti‐related peptide |
| AP | Area postrema |
| Arc | Arcuate nucleus |
| Bar | Barrington's nucleus |
| BB | Bombesin‐like peptides |
| BST | Bed nucleus of the stria terminalis |
| CART | Cocaine‐ and amphetamine‐regulated transcript |
| CCK | Cholecystokinin‐8 |
| CeA | Central amygdala |
| CRH | Corticotropin‐releasing hormone |
| CTb | Choleratoxin subunit b |
| DH | Dorsal horn of the spinal cord |
| DMH | Dorsomedial hypothalamus |
| DMV | Dorsal motor nucleus of the vagus |
| DR | Dorsal raphe |
| Dyn | Dynorphin |
| Enk | Enkephalin |
| Gal | Galanin |
| Gi | Gigantocellular nucleus |
| GLP1 | Glucagon‐like peptide‐1 |
| IC | Insular cortex |
| IL | Infralimbic cortex |
| IML | Intermediolateral column in the spinal cord |
| IRT | Intermediate reticular formation |
| IX | Glossopharyngeal nerve |
| KF | Kölliker‐Fuse nucleus |
| LC | Locus coeruleus |
| LH | Lateral hypothalamus |
| MS | Medial septum |
| NAc | Nucleus Accumbens |
| Nfat | Nesfatin‐1 |
| Nnat | Neuronatin |
| NPY | Neuropeptide Y |
| Nts | Neurotensin |
| NTS | Nucleus of the solitary tract |
| cNTS | Caudal nucleus of the solitary tract |
| OT | Oxytocin |
| OVLT | Vascular organ of lamina terminalis |
| PAG | Periaqueductal grey |
| PBN | Parabrachial nucleus |
| POMC | Proopiomelanocortin |
| PPY | Parapyramidal region |
| PrL | Prelimbic cortex |
| PrRP | Prolactin‐releasing peptide |
| PSTh | Parasubthalamic nucleus |
| PVN | Paraventricular nucleus of the hypothalamus |
| PVT | Paraventricular nucleus of the thalamus |
| RLi | Linear raphe nucleus |
| RMg | Raphe magnus |
| ROb | Raphe obscurus |
| RPa | Raphe pallidus |
| SFO | Subfornical organ |
| SI | Substantia innominata |
| Sp5 | Spinal trigeminal nucleus |
| Tac | Tachykinin/substance P |
| VH | Ventral horn of the spinal cord |
| VLM | Ventrolateral medulla |
| VMH | Ventromedial hypothalamus |
| VTA | Ventral tegmental area |
| ZI | Zona incerta |
FIGURE 3Efferent and afferent inputs to the caudal nucleus of the solitary tract (cNTS). Direct inputs to the cNTS are indicated in red boxes. Projection targets are indicated in green circles. Areas with bidirectional connections are in yellow triangles. For abbreviations, see Table 2